title: Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
abstract: BACKGROUND
  Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial.
  
  
  METHODS
  Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria.
  
  
  RESULTS
  There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P < 0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95% confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39).
  
  
  CONCLUSIONS
  Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.
authors: Oncologisch Centrum, Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Jette, Brussels, Belgium. conrvhgv@uzbrussel.be
authors: Vincent
authors: V
authors: Vinh-Hung
authors: Claire
authors: C
authors: Bourgain
authors: Georges
authors: G
authors: Vlastos
authors: Gábor
authors: G
authors: Cserni
authors: Mark
authors: M
authors: De Ridder
authors: Guy
authors: G
authors: Storme
authors: Anne-Thérèse
authors: AT
authors: Vlastos
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology; D017677:Age Distribution; D018288:Carcinoma, Small Cell / Q000453:epidemiology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data; D015994:Incidence; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D016016:Proportional Hazards Models; D044469:Racial Groups / Q000706:statistics & numerical data; D011878:Radiotherapy / Q000706:statistics & numerical data; D018426:SEER Program; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000473:pathology* / Q000628:therapy
references: Int J Cancer. 2000 May 1;86(3):429-35
references: 10760834
references: Am J Obstet Gynecol. 2003 Jul;189(1):118-20
references: 12861148
references: Cancer. 1995 Nov 15;76(10 Suppl):1948-55
references: 8634986
references: MMWR Morb Mortal Wkly Rep. 2002 Nov 29;51(47):1067-70
references: 12500907
references: J Natl Cancer Inst. 2006 Mar 1;98(5):303-15
references: 16507827
references: Br J Cancer. 2005 Nov 28;93(11):1301-4
references: 16265348
references: Int J Cancer. 1998 Feb 9;75(4):536-45
references: 9466653
references: CMAJ. 2001 Apr 17;164(8):1151-2
references: 11338801
references: Gynecol Oncol. 1979 Apr;7(2):111-22
references: 437563
references: J Pathol. 2003 Dec;201(4):535-43
references: 14648656
references: Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):485-500
references: 16150389
references: Gynecol Oncol. 2003 Aug;90(2):282-9
references: 12893188
references: Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1129-36
references: 11700260
references: Eur J Cancer. 2002 Dec;38(18):2428-34
references: 12460788
references: Int J Gynecol Cancer. 2006 May-Jun;16(3):1025-31
references: 16803480
references: Cancer Causes Control. 2006 Apr;17(3):299-306
references: 16489537
references: N Engl J Med. 2007 May 10;356(19):1928-43
references: 17494926
references: Gynecol Oncol. 2003 Dec;91(3):558-62
references: 14675676
references: Am J Pathol. 2000 Oct;157(4):1055-62
references: 11021808
references: J Epidemiol Community Health. 1995 Apr;49(2):153-7
references: 7798043
references: Am J Surg Pathol. 1998 Jan;22(1):113-20
references: 9422324
references: Vaccine. 2006 Aug 31;24 Suppl 3:S3/iii-iv
references: 16950024
references: Cancer. 1986 Apr 15;57(8):1584-93
references: 2418947
references: Gynecol Oncol. 1989 Nov;35(2):145-9
references: 2807003
references: CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28
references: 17237032
references: Cancer. 2006 Oct 15;107(8):1711-42
references: 16958083
references: Int J Gynecol Cancer. 2004 Sep-Oct;14(5):741-50
references: 15361180
references: J Natl Cancer Inst Monogr. 2003;(31):3-13
references: 12807939
references: CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
references: 16514137
references: J Pathol. 1999 Sep;189(1):12-9
references: 10451482
references: Lancet. 2006 Apr 15;367(9518):1247-55
references: 16631880
references: Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46
references: 8115784
references: JAMA. 2007 Feb 28;297(8):813-9
references: 17327523
references: Int J Cancer. 2002 Dec 1;102(4):412-7
references: 12402312
references: Sex Transm Dis. 1999 Apr;26(4 Suppl):S2-7
references: 10227693
references: Br J Cancer. 2003 Dec 1;89(11):2078-86
references: 14647141
references: Breast Cancer Res. 2004;6(6):R680-8
references: 15535850
references: Eur J Cancer. 2000 Nov;36(17):2266-71
references: 11072218
references: Gynecol Oncol. 2002 Jan;84(1):115-9
references: 11748986
references: Obstet Gynecol. 1985 Mar;65(3):416-22
references: 3974967
references: Gynecol Oncol. 1996 Dec;63(3):304-11
references: 8946863
references: Mod Pathol. 2005 Apr;18(4):528-34
references: 15502807
references: Bull Cancer. 1998 Apr;85(4):319-27
references: 9752295
references: Nat Rev Cancer. 2006 Oct;6(10):753-63
references: 16990853
references: Nat Rev Cancer. 2007 Jan;7(1):11-22
references: 17186016
references: J Natl Cancer Inst Monogr. 2003;(31):14-9
references: 12807940
references: Curr Treat Options Oncol. 2004 Apr;5(2):119-27
references: 14990206
references: Int J Cancer. 2006 Mar 15;118(6):1481-95
references: 16206285
references: Br J Cancer. 2006 Jan 16;94(1):171-5
references: 16404371
references: Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):64-9
references: 11803102
references: Am J Obstet Gynecol. 2003 Mar;188(3):657-63
references: 12634637
references: Gynecol Oncol. 1995 Oct;59(1):38-44
references: 7557613
references: Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66
references: 11602373
references: Acta Obstet Gynecol Scand. 2006;85(1):106-11
references: 16521689
references: Cancer. 2001 Nov 1;92(9):2471-83
references: 11745305
references: Lancet. 2001 May 12;357(9267):1490-3
references: 11377601
references: Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2191-9
references: 16172231
references: Cancer. 2003 Aug 15;98(4):814-21
references: 12910527
references: Cancer Detect Prev. 2004;28(6):461-4
references: 15582270
references: Virus Res. 2002 Nov;89(2):191-9
references: 12445659
references: N Engl J Med. 2007 May 10;356(19):1915-27
references: 17494925
references: J Clin Pathol. 2002 Apr;55(4):244-65
references: 11919208
references: Biomed Pharmacother. 2003 Mar;57(2):67-77
references: 12854514
references: Lancet. 2002 Mar 30;359(9312):1093-101
references: 11943256
references: Cancer Res. 2003 Nov 1;63(21):7215-20
references: 14612516
references: J Med. 1995;26(1-2):17-30
references: 7561528